Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bodi Envi vs EmbraceRX

Bodi Envi
Graded #88

Higher grade

vs+13.199999999999996
EmbraceRX
Graded #363

Lower grade

The verdict

Bodi Envi takes it — 71.8/100 to 58.6/100.

Bodi Envi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bodi Envi is a nationwide telehealth weight-loss provider offering physician-prescribed compounded semaglutide ($179/month) and tirzepatide ($249/month) at flat all-dose pricing with no consultation or…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBodi Envi +28
73
45
Dose & formulationBodi Envi +16
72
56
Clinical oversightBodi Envi +6
82
76
Labs & monitoringBodi Envi +12
64
52
FulfillmentEmbraceRX +4
69
73
Contract termsBodi Envi +6
61
55
Bodi Envi · left barEmbraceRX · right bar

The numbers

MetricBodi EnviEmbraceRX
WeighScore71.8/10058.6/100
GradeCC
Scorecard rank#88#363
Semaglutide$179/moNot disclosed
Tirzepatide$249/moNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Bodi Envi

Graded #88 · C

Strengths

  • Transparent flat pricing: compounded semaglutide $179/month and tirzepatide $249/month, all doses
  • No consultation or membership fees
  • Free 2-day shipping included; FSA and HSA eligible
  • 24/7 secure provider messaging with same-day visits and prescriptions
  • Personalized dose titration with side-effect management (Zofran available)

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No insurance billing — cash-pay only
  • States served are not explicitly listed (features vary by state)
  • No LegitScript certification visible on the site
EmbraceRX

Graded #363 · C

Strengths

  • Broad compounded GLP-1 menu — semaglutide (+B12), tirzepatide, oral semaglutide/tirzepatide capsules, plus Lipo-B
  • Large peptide/longevity catalog (BPC-157, GHK-Cu, NAD+, MOTS-C) across injectable, oral, topical, and nasal formats
  • Clinician-guided, compounded at FDA-registered pharmacies; partners with a licensed physician network (Samaritan MD)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, CCPA, Returns & Refunds)

Where it loses points

  • Pricing not shown upfront — revealed only at checkout after a dose selection
  • Offers investigational/research compounds (e.g., retatrutide, AOD-9604) that are not FDA-approved
  • Compounding pharmacy partner not named ('FDA-registered pharmacies')
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard